�鶹��ýӰ��

Meeting Coverage >

ACR

Is JAK Inhibition the Next Big Thing in PsA?

Proof-of-concept study suggests a potential role for oral filgotinib

New JAK1 Agent Beats Humira in Rheumatoid Arthritis

Thrombotic events balanced between upadacitinib, adalimumab, and placebo

Can Imaging Replace Biopsy for GCA Diagnosis?

Ultrasound, PET/CT may offer advantages

Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trial

Risankizumab broadly effective against joint and skin symptoms

PsA Structural Damage Inhibited with Secukinumab

Loading dose appears to improve outcomes, researchers say

Novel Drug Promising for IgG4-Related Disease

8 of 15 patients achieved remission in phase II study

Prospects Good for Ustekinumab Gaining SLE Indication

Positive phase II data reported in ACR late-breaker

ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologics

Selections from late-breaker poster presentations at rheumatology meeting

Mixed Results in Studies of Biosimilar-Originator Switching

Is there a nocebo effect in changing between drugs supposed to be equal?

Biologics During Pregnancy Don't Raise Infection Risk for Infants

Gestational timing of exposure to biologic not an issue

Tool Available to Help Rheumatologists Cope with MIPS

Eases reporting needed to avoid penalties, earn incentive payments under MACRA

Lipid Changes with Sirukumab Called 'Anti-Atherogenic'

Looking for silver-lining in cloudy trial data

Bruton's Tyrosine Kinase Marches on as Rheumatology Target

Industry remains interested despite lackluster phase II results with Celgene drug

In RA Patients, 2-Week Methotrexate Holiday Boosts Flu Vax Efficacy

Pragmatic trial shows 15%-20% bump in antibody titers

ACR 2017: Biosimilar Debate, Inflammation in OA, and More

Special lecture will look back at TNF as rheumatology drug target

Knee OA No Excuse to Skip Out on Physical Activity

Patients met thresholds for sit-to-stand, gait speed, and walking speed

Lowering Urate Helps Renal Function

Most improvement seen in stage 3 chronic kidney disease

Pro Soccer Career: A Risk Factor for Osteoarthritis in Men

Study also suggests controversial joint injections hike OA risk

Reassuring Cancer Data With JIA Tx

No apparent increase in risk with anti-TNF treatment

Two RA Agents Similar in Head-to-Head Trial

Sponsor's hopes of proving Cimzia's superiority to Humira dashed

ACR: Actemra Found Steroid-Sparing in GCA

The era of unending steroid treatment is over

Rheumatology Faces Serious Manpower Shortage

Supply of full-time docs will drop over the next 15 years

Stroke Spike Seen in Autoimmune Disorders After Shingles Attacks

Risk increased by 50% in the first month

Does an IUD and Family History Boost RA Risk?

RA-associated autoantibodies tied to IUDs in at-risk women.

Gout May Protect Against Alzheimer's Disease

Study showed AD incidence higher over 5 years for patients without gout.

Humira Benefits Persist in Spine Disease

Anti-TNF treatment efficacy maintained at 3 years in axial spondyloarthritis.

Osteonecrosis of the Jaw Is Rare With Denosumab for Bone Loss

Study finds risk very low, even with long-term drug therapy.

Otezla Benefit Durable in PsA

Benefits persist through 2 years with apremilast in psoriatic arthritis.

A Role for the Microbiome for Arthritis in Kids?

Study links antibiotics to JIA risk.

Infection Risk Seen as Minimal With Denosumab

No increased risk whether administered alone or with DMARDs.

Lung Transplant Valid in SSc

Patients with systemic sclerosis shouldn't be denied lung transplants.

Gout Patients Wind up in the Hospital Unnecessarily

Single-center study estimates frequency of preventable admissions.

Autoantibodies a Big Deal in Sjogren’s

SAN DIEGO -- A broader range of autoantibodies may play a role in Sjogren's syndrome than has previously been appreciated, researchers found.

Mom's Lupus Tied to Child's Autism

SAN DIEGO -- Children born to mothers with systemic lupus erythematosus have twice the risk for autism spectrum disorders as those whose mothers are unaffected, a Canadian researcher reported here.

Antidepressants, Lyrica OK Combo in Fibromyalgia

SAN DIEGO -- Patients with fibromyalgia who were taking antidepressants found that their pain was successfully managed with pregabalin (Lyrica), a researcher said here.

Few Lupus, IBD Patients Getting HPV Vaccine

SAN DIEGO -- Despite being at greater risk of infection, few children and young adults with autoimmune diseases are being vaccinated against human papillomavirus, according to a study.

Lupus Patients Tend to Skip Pap Tests

WASHINGTON -- Women with systemic lupus erythematosus do not appear undergo timely cervical cancer screening despite being at an increased risk for cervical dysplasia and HPV infection, researchers said here.

TB No Barrier to Anti-TNF Treatment

WASHINGTON -- Patients being treated with tumor necrosis factor inhibitors who develop tuberculosis may safely reinstitute their biologic before completing the lengthy TB treatment regimen, a retrospective study suggested.

Enbrel Best for RA If Taken Over Long Term

WASHINGTON -- Most rheumatoid arthritis patients who achieve a state of low disease activity taking etanercept (Enbrel) fare better if they remain on therapy, even if only at a lower dose, a researcher reported here.

ACR: Enbrel May Be Enough for Some RA Patients

CHICAGO -- Monotherapy with etanercept (Enbrel) can keep some rheumatoid arthritis (RA) patients in long-term remission, researchers said here.

2